Paclitaxel
Product Description
Chongqing Sintaho Pharmaceutical Co., Ltd.
-
Country/Region:China
-
On CPHI since:2023
-
Certificates:4
-
Employees:250 - 499
Company types
Primary activities
Categories
Specifications
Chongqing Sintaho Pharmaceutical Co., Ltd.
-
Country/Region:China
-
On CPHI since:2023
-
Certificates:4
-
Employees:250 - 499
Company types
Primary activities
More Products from Chongqing Sintaho Pharmaceutical Co., Ltd. (4)
-
Product Eribulin Mesylate
Eribulin (E7389) mesylate is a microtubule targeting agent that is used for the research of metastatic breast cancer. Eribulin mesylate inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules. -
Product Deruxtecan
Deruxtecan is an ADC drug-linker conjugate composed of an DX-8951 derivative (DXd) and a maleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402. -
Product Exatecan Mesylate
Exatecan mesylate (DX8951f) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL). Exatecan mesylate can be used in cancer research. -
Product MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH
MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).